Gary Wyetzner Discloses 30,607 Shares in Regis Corp (RGS)

TL;DR

**New investor Gary Wyetzner just disclosed a stake in Regis Corp, signaling potential future activism.**

AI Summary

Gary Wyetzner, a U.S. citizen, has filed an SC 13D indicating beneficial ownership of 30,607 shares of Regis Corporation's Common Stock, representing less than 1% of the class. This filing, dated January 9, 2024, suggests he is part of a group, though the other members' holdings aren't detailed in this excerpt. For current or prospective shareholders, this matters because it signals a new, potentially activist, investor taking a position in Regis Corp, which could lead to future strategic changes or demands.

Why It Matters

A new investor taking a significant, though not controlling, stake could signal upcoming pressure for operational changes or a strategic review at Regis Corp.

Risk Assessment

Risk Level: medium — While the stake is small, the SC 13D filing indicates potential group activity, which could lead to corporate changes, introducing both upside and downside risk.

Analyst Insight

Investors should monitor future filings from Gary Wyetzner and any associated group members for further details on their collective stake and stated intentions, as this could signal upcoming activist pressure or strategic changes at Regis Corp.

Key Numbers

• 30,607 — Shares Beneficially Owned (Number of Regis Corp Common Stock shares Gary Wyetzner has sole voting and dispositive power over.)
• $0.05 — Par Value per Share (The stated par value of Regis Corporation's Common Stock.)
• 758932206 — CUSIP Number (Unique identification number for Regis Corporation's Common Stock.)
• January 9, 2024 — Date of Event (The date that triggered the requirement for this SC 13D filing.)

Key Players & Entities

• Gary Wyetzner (person) — Reporting Person, beneficial owner of Regis Corp shares
• Regis Corporation (company) — Issuer of the Common Stock
• William Charters (person) — Contact person for notices and communications
• Stephen Salvadore (person) — Contact person for notices and communications
• Christopher P. Davis (person) — Attorney at Kleinberg, Kaplan, Wolff & Cohen, P.C.
• Kleinberg, Kaplan, Wolff & Cohen, P.C. (company) — Law firm providing counsel

Forward-Looking Statements

• Gary Wyetzner, potentially with a group, will seek to engage with Regis Corp management regarding strategic direction. (Regis Corporation) — medium confidence, target: Within 6-12 months
• The group's full beneficial ownership will be disclosed in subsequent filings, potentially revealing a larger collective stake. (Gary Wyetzner) — medium confidence, target: Within 3 months

FAQ

Key Financial Figures

• $0.05 — ration (Name of Issuer) Common Stock, $0.05 par value per share (Title of Class of
• $3,006,711.65 — ported in Item 5(a,b) was approximately $3,006,711.65. The source of funds for purchases of S
• $7.60 — yetzner 11/10/2023 BUY Common Stock $7.60 265 11/17/2023 BUY Common Stock $8
• $8.40 — 60 265 11/17/2023 BUY Common Stock $8.40 5 12/14/2023 BUY Common Stock $7.7
• $7.74 — 8.40 5 12/14/2023 BUY Common Stock $7.74 130 12/15/2023 BUY Common Stock $6
• $6.59 — 74 130 12/15/2023 BUY Common Stock $6.59 475 Stephen Salvadore 12/20/2023 SE
• $6.18 — vadore 12/20/2023 SELL Common Stock $6.18 (916) 12/21/2023 SELL Common Stock
• $6.10 — (916) 12/21/2023 SELL Common Stock $6.10 (1,300) 12/26/2023 SELL Common Stoc
• $6.02 — 1,300) 12/26/2023 SELL Common Stock $6.02 (6,000) Barbara Salvadore 12/29/2023
• $9.56 — lvadore 12/29/2023 BUY Common Stock $9.56 8,920 1/2/2024 BUY Common Stock $9
• $9.00 — 56 8,920 1/2/2024 BUY Common Stock $9.00 1,385 William Charters 11/13/2023 B
• $8.00 — harters 11/13/2023 BUY Common Stock $8.00 1,722 11/14/2023 BUY Common Stock
• $9.60 — 1,722 11/14/2023 BUY Common Stock $9.60 2,028 11/15/2023 BUY Common Stock
• $10.00 — 2,028 11/15/2023 BUY Common Stock $10.00 1,250 11/27/2023 BUY Common Stock
• $7.20 — 1,250 11/27/2023 BUY Common Stock $7.20 3,853 11/28/2023 BUY Common Stock

Filing Documents

• regis13d-01092024.htm (SC 13D) — 134KB
• ex992toregis13d-01092024.htm (EX-99.2) — 23KB
• 0001013594-24-000022.txt ( ) — 158KB

Security and Issuer

Item 1. Security and Issuer. This Schedule 13D (the " Schedule 13D ") is being filed with respect to the shares of common stock (the " Shares ") of Regis Corporation, a Minnesota corporation (the " Company ").

Identity and Background

Item 2. Identity and Background. (a) This Schedule 13D is being filed on behalf of the following Reporting Persons (collectively, the " Reporting Persons "): Gary Wyetzner, Stephen Salvadore, Aurora Salvadore, Barbara Salvadore and William Charters, each of whom is a United States citizen. (b) The business address of Mr. Wyetzner is 64 Norris Avenue, Metuchen, NJ 08840. The business address of Stephen Salvadore, Aurora Salvadore and Barbara Salvadore is 38 Sunset Drive, East Greenwich, RI 02818. The business address of Mr. Charters is 5537 Newcastle Lane, Calabasas, CA 91302. (c) The principal occupation of Mr. Wyetzner is as an independent financial strategist. The principal occupation of Mr. Salvadore is as a venture capitalist. The principal occupation of Aurora Salvadore is as an interior designer. Barbara Salvadore is retired, and has no principal occupation. The principal occupation of Mr. Charters is an investor. (d, e) During the past five years, no Reporting Person has been convicted in a criminal proceeding, or been a party to a civil proceeding, required to be disclosed pursuant to Items 2(d) or (e) of Schedule 13D. (f) The citizenship of each of the Reporting Persons is set forth in paragraph (a) of this Item.

Source and Amount of Funds or Other Consideration

Item 3. Source and Amount of Funds or Other Consideration. The total amount of funds used by the Reporting Persons to make all purchases of Shares beneficially owned by the Reporting Persons, as reported in Item 5(a,b) was approximately $3,006,711.65. The source of funds for purchases of Shares by each of the Reporting Persons is the personal funds of the applicable Reporting Person.

Purpose of Transaction

Item 4. Purpose of Transaction On January 8, 2024, the Reporting Persons issued a letter (the " Letter ") to the chairman of the board of directors of the Issuer. The Letter is attached hereto as Exhibit 99.2 . The public is encouraged to read the Letter and form its own opinions. The Reporting Persons believe the securities of the Issuer are significantly undervalued and represent an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of securities of the Issuer at prices that would make the purchase or sale of such securities desirable, the Reporting Persons may endeavor (i) to increase or decrease their respective positions in the Issuer through, among other things, the purchase or sale of securities of the Issuer on the open market or in private transactions, including through a trading plan created under Rule 10b5-1(c) or otherwise, on such terms and at such times as the Reporting Persons may deem advisable and/or (ii) to enter into transactions that increase or hedge their economic exposure to the Common Stock without affecting their beneficial ownership of shares of Common Stock. Except as set forth in the Letter, no Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Persons may develop additional plans and/or make further proposals with respect to, or with respect to potential changes in, the operations, management, the certificate of incorporation and bylaws, Board composition, ownership, capital or corporate structure, dividend policy, strategy and plans of the Issuer, potential strategic transactions involving the Issuer or certain of the Issuer's businesses or assets, or m

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer (a) The aggregate percentage of Shares reported owned by each person named herein is based upon 2,279,417 Shares outstanding as of November 29, 2023, which is the total number of Shares outstanding as reported in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on December 1, 2023. As of the close of business on the date hereof, Mr. Wyetzner individually beneficially owned 30,607 Shares, constituting approximately 1.34% of all of the outstanding Shares. As of the close of business on the date hereof, Mr. Salvadore individually beneficially owned 27,569 Shares, constituting approximately 1.21% of all of the outstanding Shares. As of the close of business on the date hereof, Aurora Salvadore individually beneficially owned 4,055 Shares, constituting approximately 0.18% of all of the outstanding Shares. As of the close of business on the date hereof, Barbara Salvadore individually beneficially owned 31,000 Shares, constituting approximately 1.36% of all of the outstanding Shares. Mr. Salvadore may be deemed to beneficially own the 4,055 Shares held by Aurora Salvadore and the 31,000 Shares held by Barbara Salvadore by virtue of his position as investment manager of the accounts holding such Shares. As of the close of business on the date hereof, Mr. Charters individually beneficially owned 80,000 Shares, constituting approximately 3.51% of all of the outstanding Shares. The Reporting Persons, in the aggregate, beneficially own 173,231 Shares, constituting approximately 7.6% of the outstanding Shares. (b) Mr. Wyetzner has sole power (i) to vote or direct the vote of, and (ii) to dispose or direct the disposition of, 30,607 Shares held by Mr. Wyetzner. Mr. Salvadore has sole power (i) to vote or direct the vote of, and (ii) to dispose or direct the disposition of, the 27,569 Shares held by Mr. Salvadore. Mr. Salvadore has shared power with Aurora Salvadore power (i) to vote o

Contracts, Arrangements, Understandings or Relationships with Respect

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. The Reporting Persons have entered into a joint filing agreement, dated as of January 5, 2024, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference .

Material to be filed as Exhibits

Item 7. Material to be filed as Exhibits Exhibit 99.1 Joint Filing Agreement to Schedule 13D-G by and among Gary Wyetzner, Stephen Salvadore, Aurora Salvadore, Barbara Salvadore and William Charters, dated as of January 9, 2024 . Exhibit 99.2 Letter to the Chairman of the Board of Directors of Regis Corporation, dated as of January 9, 2024 . SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in the Dated: January 9, 2024 /s/ Gary Wyetzner GARY WYETZNER /s/ Stephen Salvadore STEPHEN SALVADORE /s/ Aurora Salvadore AURORA SALVADORE /s/ Barbara Salvadore BARBARA SALVADORE /s/ William Charters WILLIAM CHARTERS SCHEDULE 1 Transactions in the Common Stock of the Issuer by Reporting Persons During the Past 60 Days Date Buy/Sell Security Approximate Price Per Share 1 2 Amount of Shares Bought/(Sold) 3 Gary Wyetzner 11/10/2023 BUY Common Stock $7.60 265 11/17/2023 BUY Common Stock $8.40 5 12/14/2023 BUY Common Stock $7.74 130 12/15/2023 BUY Common Stock $6.59 475 Stephen Salvadore 12/20/2023 SELL Common Stock $6.18 (916) 12/21/2023 SELL Common Stock $6.10 (1,300) 12/26/2023 SELL Common Stock $6.02 (6,000) Barbara Salvadore 12/29/2023 BUY Common Stock $9.56 8,920 1/2/2024 BUY Common Stock $9.00 1,385 William Charters 11/13/2023 BUY Common Stock $8.00 1,722 11/14/2023 BUY Common Stock $9.60 2,028 11/15/2023 BUY Common Stock $10.00 1,250 11/27/2023 BUY Common Stock $7.20 3,853 11/28/2023 BUY Common Stock $7.00 3,647 11/29/2023 BUY Common Stock $7.21 10,750 11/30/2023 BUY Common Stock $7.87 3,000 12/1/2023 BUY Common Stock $6.80 2,000 12/4/2023 BUY Common Stock $6.75 8,000 12/5/2023 BUY Common Stock $6.66 2,000 12/6/2023 BUY Common Stock $6.77 1,000 12/8/2023 SELL Common Stock $9.43 (880) 12/8/2023 BUY Co

View Full Filing

View this SC 13D filing on SEC EDGAR